Dendrobium huoshanense carbon glycosyl transferase and application thereof

By providing the C-glycosyltransferase gene and enzyme synthesis method of Dendrobium Huoshan, the complexity and pollution problems of existing chemical synthesis methods are solved, and the efficient and low-pollution biosynthesis of flavonoid carbonins are achieved, suitable for 4-42℃ The temperature range and no metal ions are required, significantly improving the synthesis efficiency and safety.

CN118879656AInactive Publication Date: 2024-11-01WEST ANHUI UNIV
View PDF 0 Cites 1 Cited by

Patent Information

Application Number
CN202410785981.9
Authority / Receiving Office
CN · China
Patent Type
Applications(China)
Current Assignee / Owner
Filing Date
2024-06-18
Publication Date
2024-11-01
Estimated Expiration
Not applicable · inactive patent

AI Technical Summary

Technical Problem

The existing chemical synthesis methods used to generate flavonoid carbonins have complex steps, large contamination, and not single products. There is a lack of literature reports on Dendrobium Huoshan, which makes it difficult to develop an effective synthesis method.

Method used

Provide a C-glycosyltransferase gene and its amino acid sequence to catalyze the generation of flavonoid carbonosidic compounds, obtain C-glycosyltransferase through prokaryotic expression by enzyme synthesis, and catalyze the synthesis of flavonoids in the enzyme-active reaction system Carbon glycoside, the suitable temperature range is 4-42°C, and there is no metal ion dependence.

Benefits of technology

A simple and low-pollution flavonoid carbonins biosynthesis is achieved, and the products are more single, and the appropriate temperature range and metal ion dependence are improved to improve the efficiency and safety of synthesis.

✦ Generated by Eureka AI based on patent content.

Smart Images

  • Figure CN118879656A_ABST
    Figure CN118879656A_ABST
Patent Text Reader

Abstract

The invention discloses application of carbon glycosyl transferase coded by a dendrobium huoshanense DhUGT31 gene in biosynthesis of flavone C-glycoside, and belongs to the technical field of biology. The nucleotide sequence of the DhUGT31 gene encodes a nucleotide sequence of an amino acid sequence as shown in SEQ ID NO. 2. The flavone C-glycoside is obtained by a biological synthesis method for carrying out enzyme catalysis by utilizing the DhUGT31 protein in vitro, and a new method is provided for synthesizing the flavone C-glycoside.
Need to check novelty before this filing date? Find Prior Art

Description

Technical Field

[0001] The invention belongs to the field of biotechnology, and specifically relates to Dendrobium huoshanense C-glycosyltransferase and application thereof. Background Art

[0002] Flavonoid glycosides are a class of important natural products with strong biological activity and high stability. Currently, about 800 glycoside components have been reported from plants, of which 80% are flavonoid glycosides. Studies have shown that flavonoid glycosides have pharmacological activities such as antibacterial, antioxidant, antitumor, hepatoprotective, antidiabetic, anti-inflammatory and antiviral. Because they have stable CC glycosidic bonds and are not easily degraded, they have better pharmacokinetic properties and bioavailability and are easier to develop into drugs. For example, vitexin and isovitexin in Dendrobium huoshanense have good anti-inflammatory, antitumor, antioxidant, antibacterial and hepatoprotective activities in clinical practice; puerarin isolated from the traditional Chinese medicine Pueraria montana has been developed into a clinical drug for the treatment of cardiovascular diseases such as hypertension and type II diabetes; aloin extracted from aloe vera has the ability to inhibit pigmentation caused by ultraviolet radiation and inhibit tyrosinase activity, and is an important active ingredient in many skin care products; in plants, the body resists biotic and abiotic stresses in the environment by regulating the expression levels of key genes in the synthesis pathways of flavonoid glycosides. For example, Amblin found that the survival rate of rice with the flavonoid glycosyltransferase gene under ultraviolet light was 40% higher than that of the wild type. Xu et al. found that the content of flavonoid glycosides in disease-resistant rice increased significantly after being attacked by brown planthoppers, while no obvious changes in the content of secondary metabolites were observed in susceptible rice. Flavonoid glycosides are mainly synthesized by chemical synthesis and enzyme synthesis. The chemical synthesis method has harsh reaction conditions, involves organic reagents, has a low yield, and is prone to produce by-products that are harmful to the environment and human body. It is not the best choice for synthesizing flavonoid glycosides. In comparison, the enzyme synthesis method is more suitable. So far, no reports on the glycosyltransferase in the literature of Dendrobium Huoshanense have been found. Therefore, it is of great significance to identify and develop enzymes and methods with flavonoid glycoside synthesis function. Summary of the invention

[0003] The present invention mainly aims at the above technical problems and provides a C-glycosyltransferase gene for catalyzing the production of flavonoid carbon glycoside compounds and a method for biosynthesizing flavonoid carbon glycoside compounds to solve the shortcomings of existing chemical synthesis of flavonoid carbon glycosides.

[0004] Specifically, the present invention provides the following technical solutions:

[0005] In one aspect, the present invention provides a C-glycosyltransferase, whose amino acid sequence comprises the sequence shown in SEQ ID NO.2.

[0006] In another aspect, the present invention provides a C-glycosyltransferase gene, the sequence of which is a nucleotide sequence encoding an amino acid sequence as shown in SEQ ID NO.2,

[0007] Or based on the principle of complementary pairing, the C-glycosyltransferase gene provided by the present invention can be a sequence that is fully complementary to the nucleotide sequence encoding the amino acid sequence shown in SEQ ID NO.2.

[0008] In a preferred embodiment, the nucleotide sequence of the C-glycosyltransferase gene comprises a nucleotide sequence as shown in SEQ ID NO: 1, or a nucleotide sequence that is completely complementary to the sequence shown in SEQ ID NO. 1.

[0009] It is well known to those skilled in the art that a gene sequence may also contain introns, promoters and various regulatory elements, and thus the nucleotide sequence of the C-glycosyltransferase gene may also contain introns, promoters and various regulatory elements.

[0010] On the other hand, the present invention provides an application of a C-glycosyltransferase gene in the synthesis of flavonoid carbon glycoside compounds, wherein the nucleic acid sequence of the C-glycosyltransferase gene is a nucleotide sequence encoding an amino acid sequence as shown in SEQ ID NO.2, or a sequence that is fully complementary to a nucleotide sequence encoding an amino acid sequence as shown in SEQ ID NO.2.

[0011] In a preferred embodiment, the C-glycosyltransferase gene sequence is a nucleotide sequence encoding the amino acid sequence shown in SEQ ID NO.2, or a sequence that is completely complementary to the nucleotide sequence encoding the amino acid sequence shown in SEQ ID NO.2.

[0012] In a preferred embodiment, the nucleotide sequence of the C-glycosyltransferase gene is as shown in SEQ ID NO: 1, or a nucleotide sequence that is completely complementary to the sequence shown in SEQ ID NO. 1.

[0013] On the other hand, the present invention provides the use of the aforementioned C-glycosyltransferase in the synthesis of flavonoid carbon glycoside compounds.

[0014] In another aspect, the present invention provides a method for synthesizing flavonoid glycoside compounds, the method comprising the following steps:

[0015] 1) obtaining the aforementioned C-glycosyltransferase;

[0016] 2) Using the C-glycosyltransferase in step 1) to catalyze the synthesis of flavonoid carbonyl glycosides in an enzyme activity reaction system.

[0017] In a preferred embodiment, the above C-glycosyltransferase is obtained by prokaryotic expression.

[0018] In a preferred embodiment, the above C-glycosyltransferase is obtained by chemical synthesis.

[0019] In a preferred embodiment, the enzyme activity reaction system contains the above-mentioned C-glycosyltransferase, UDP-Glc, a substrate for synthesizing flavonoid carbon glycoside compounds and a buffer.

[0020] In another aspect, the present invention provides a method for synthesizing flavonoid glycoside compounds, characterized in that the method comprises the following steps:

[0021] 1) obtaining a C-glycosyltransferase comprising the amino acid sequence shown in SEQ ID NO.2;

[0022] 2) Using the above C-glycosyltransferase to catalyze the synthesis of flavonoid carbonyl glycoside compounds in an enzyme activity reaction system.

[0023] In a preferred embodiment, the above C-glycosyltransferase is obtained by prokaryotic expression.

[0024] In a preferred embodiment, the above C-glycosyltransferase is obtained by chemical synthesis.

[0025] In a preferred embodiment, the enzyme activity reaction system contains the above-mentioned C-glycosyltransferase, UDP-Glc, a substrate for synthesizing flavonoid carbon glycoside compounds and a buffer.

[0026] In a preferred embodiment, the enzyme activity reaction system also contains divalent cations.

[0027] In a preferred embodiment, the reaction temperature of the enzyme activity reaction system is 4-42°C.

[0028] In a preferred embodiment, the pH of the enzyme activity reaction system is 6.0-10.0.

[0029] Compared with the prior art, the present invention has the following advantages:

[0030] 1) Compared with the prior art, the present invention uses an enzyme-catalyzed biosynthesis method to obtain flavonoid carbonyl glycosides, which has the advantages of simpler steps, less pollution, and more uniform products compared with chemical synthesis methods.

[0031] 2) The glycosyltransferase in the present invention has a wide temperature range (4 to 42° C.) for its suitable reaction.

[0032] 3) The glycosyltransferase in the present invention is not metal ion dependent. BRIEF DESCRIPTION OF THE DRAWINGS

[0033] The method of the present invention and its beneficial effects are described in detail below in conjunction with the accompanying drawings and specific implementation methods.

[0034] Figure 1 The RNA extracted from Dendrobium huoshanense, the cloned gene fragments and the colony PCR results. A: extracted RNA; B: gene cloning, where lane 5 is DhUGT31; C: bacterial solution PCR of the target gene, M in the figure represents DNA Marker,

[0035] The sizes are 2000, 1000, 750, 500, 250, and 100 bp, respectively, with lane 5 being DhUGT31.

[0036] Figure 2 The figure is the SDS-PAGE gel electrophoresis diagram of the pET-28a(+)-DhUGT31 fusion protein. Figure A is the electrophoresis result of the crude enzyme, the Marker size is 25-180kDa, where M is the protein Marker (10-180kDa), lane 4 is DhUGT31, and lane 5 is the pET-28a(+) empty vector; Figure B is the pure enzyme, where M is the protein Marker (25-150kDa) and lane 4 is DhUGT31.

[0037] Figure 3 The results of the reaction of DhUGT31 with the substrate and the schematic diagram of the catalytic activity, A: liquid phase diagram of the reaction of DhUGT31 with 2-hydroxynaringenin; B: schematic diagram of the catalytic activity of DhUGT31; C: MS graph of the monosaccharide product (23-a or 23-b); D: MS graph of the disaccharide product (23-c), 23-a, 23-b, 23-c are vitexin, isovitexin and nevedocanthin, respectively.

[0038] Figure 4 This is the result diagram of the enzymatic kinetic parameters of the pET-28a(+)-DhUGT31 fusion protein, where A is the reaction temperature, B is the reaction pH, C is the divalent metal ion, D is the reaction time, and E is the Michaelis constant. DETAILED DESCRIPTION

[0039] The technical solutions in the embodiments of the present invention are described clearly and completely below. Obviously, the described embodiments are only part of the embodiments of the present invention, not all of the embodiments. Based on the embodiments of the present invention, all other embodiments obtained by ordinary technicians in this field without creative work are within the scope of protection of the present invention.

[0040] Unless otherwise defined, all technical and scientific terms used in this application have the same meaning as commonly understood by ordinary technicians in the technical field to which this application belongs.

[0041] Example 1

[0042] Cloning of target C-glycosyltransferase gene

[0043] 1. Total RNA extraction kit was used to extract total RNA from Dendrobium huoshanense ( Figure 1 A), and a reverse transcription kit with a gDNA wiper was used to generate single-stranded cDNA, which was used as a template for polymerase chain reaction (PCR) amplification of the full-length fragment of the DhUGT31 gene. The specific primer information is shown in Table 1:

[0044] Table 1 Primers sequence

[0045]

[0046] The PCR reaction system was: 2×Phanta Max Master Mix (Dye Plus) (P515, Nanjing Novozyme Biotechnology Co., Ltd.) 25 μL, upstream and downstream primers 2 μL each, template 50-100 ng, dd H2O to 50 μL. The PCR amplification program was: ① 95℃ reaction for 3 min; ② 95℃ reaction for 15 s, 60℃ reaction for 45 s, 72℃ reaction for 60 s, a total of 35 cycles; ③ 72℃ extension for 5 min. After the reaction, the product size was detected by 1% agarose gel electrophoresis. The electrophoresis diagram is shown in Figure 1 B (M: DL 2000 marker; Lane 5: DhUGT31 gene)

[0047] 2. Connect the amplified product to the T vector (C601, Nanjing Novozyme Biotechnology Co., Ltd.), and transform it into Escherichia coli DH5α. Select a single colony and culture it in LB medium and perform PCR verification on the bacterial solution ( Figure 1 C: M: DL2000 marker; Lane 5: DhUGT31 gene), bacterial solution PCR reaction system: 12.5 μL Green Taq Mix (P131, Nanjing Novozymes Biotech Co., Ltd.), 1 μL of upstream and downstream primers, 2 μL template (bacterial solution), supplemented to 25 μL with dd H2O. Samples with correct bacterial solution PCR results were sent for sequencing.

[0048] The nucleotide sequence obtained by sequencing is shown in SEQ ID NO.1. The gene sequence contains 1359 nucleotides and encodes 452 amino acids (shown in SEQ ID NO.2).

[0049] >SEQ ID NO.1

[0050] ATGTCCTCAGGCGACACTAACCTGCCTCGCGTCCTTCTCCTCCCGAGCTCCGGCATGGGCCATCTCGTTCCCTTCGTTCG

[0051] CCTTGCCAGCGCGCTTTCCGACCGCCGCATCTCAGTCTCTCTCCTCGCTGTCCGCCCCACCATATCCGCCGCCGAATCTG

[0052] TCCTCCTATCCTCCCTCCCATCATCCCTCCTTATCGACTTCCCCATCAAACCTCTCGATCCCTCTCTCTTTCCCCCATCC

[0053] TCGGACCCCTTCTTCCTCCAAATGGAAGTTCTTCGCCGCTCAGCCGACCTACTACCTTCTTTCATCTCCACCTGCTCACC

[0054] ACCTGTCTCCTCCCTCATCATAGATATCTCCATCGCCTCCTCCTTTCTACCAGTTGCTGCCGCCGCGAAAATCCCCTGCTTCGTCCTTTTCACCTCCTCTGCTTCCATGCTCGCTCTTTGCTCTGTTTTCGCCTTCCTCTCCAAACCCACCG...GTGCT GACGTTAACATCGCCGGCGGCATCCTCAAGATTCCAAATTCCTCTCTCCCGCCGCCTCTCCGTGACCCGAACCACCTCTTCGCCACCCAATTCGTGGAGAACGGTCGGGCGCTTGCTCAAGCAAACGGTATCCTCGTGAATACATTTTCCGCATTGGAGCCTGAAGTACTCGTTGCGCTCAACTCCGGCGCGGTTCTTCCCGGACTCCCGCCGGTGATTTCTATAGGCCCATTGCCTCCGGTAAAAAAGCAACCATCTTTGCCCTCGCTAGCACTACGGTGGCTCGATAAACAGCCGGAGAAGTCGGTGATGTACGTGAGCTTCGGAAGTCGTACGGAGATGTCGAAGGAACAAATCAGAGCATTGGGTGCCGGGCTGGAGATTAGCGGGTGTCGGTTTTTCTGGGTGGTGAAAAGCGCGAAGGTGGATAGAGAAGAGGTAGTGGAGATTGAGGAATTATTGGGAAAAGAGTATGCGAAGAGAGTGGAAGAGAGAGGATTGGTGGTGAAGGAGTGGGTGGAGCAGGAGGTGGTTCTTGCTCACCGCGCGGTAGCCGGATTCATGAGCCACTGTGGTTGGAATTCAGTGACGGAGGCGGCGGCGGCGGGGGTGAGGATCCTCGCATGGCCGAGAATAGGAGATCAAAGAGTGAATGCGGCGGTGGTGGCTAGAAGCGGACTGGGAATATGGCCGGAGAAGTGGGCGTGGGAGGCTGAAGAAAGAGTCGTGGCGGCGGAGGAGATTGCGGTGAAGGTGAGGGAGGTGATGGGAGATGAGAGGGTGGCCGAGACGGCGGCGCAGGTCCGAGCGGAGGCCACGGCGGCGGTTCAGGAAGGTGGGAGCTCGGATCAGAGCTGCGGCAATTTGTTAAAGAAATTGTGA.

[0055] >SEQ ID NO.2

[0056] MSSGDTNLPRVLLLPSSGMGHLVPFVRLASALSDRRISVSLLAVRPTISAAESVLLSSLPSSLLIDFPIKPLDPSLFPPS

[0057] SDPFFLQMEVLRRSADLLPSFISTCSPPVSSLIIDISIASSFLPVAAAAKIPCFVLFTSSASMLALCSVFAFLSKPTGAD

[0058] VNIAGGILKIPNSSLPPPLRDPNHLFATQFVENGRALAQANGILVNTFSALEPEVLVALNSGAVLPGLPPVISIGPLPPV

[0059] KKQPSLPSLALRWLDKQPEKSVMYVSFGSRTEMSKEQIRALGAGLEISGCRFFWVVKSAKVDREEVVEIEELLGKEYAKR

[0060] VEERGLVVKEWVEQEVVLAHRAVAGFMSHCGWNSVTEAAAAGVRILAWPRIGDQRVNAAVVARSGLGIWPEKWAWEAEER

[0061] VVAAEEIAVKVREVMGDERVAETAAQVRAEATAAVQEGGSSDQSCGNLLKKL

[0062] Example 2 Induced expression and purification of DhUGT31 protein

[0063] Expand the target bacterial solution with correct sequencing and extract the recombinant plasmid pET-28a-DhCGTs. Transform the recombinant plasmid into E. coli BL21 (DE3) competent cells, plate, and select clones to LB medium, culture at 37°C, 200rpm, and obtain the mother solution for 16 hours. Inoculate the mother solution into LB medium containing 50μg / mL KaN at a ratio of 1:100 and culture at 37°C until OD 600 =0.6-0.8 (with sterile LB medium as control), add IPTG with a final concentration of 0.5 mM, and finally culture at 16°C, 200 rpm for 18-20 h.

[0064] Collect the induced expression bacterial solution by centrifugation, resuspend the bacteria in pre-cooled Tris-HCl (50mM) buffer at pH=8.0, centrifuge, collect the bacteria again, and repeat once to remove the residual culture medium. Finally, add 15mL of the above Tris-HCl buffer per gram of wet bacteria. The obtained bacterial suspension can be frozen in a -20℃ refrigerator overnight, and then low-temperature crushed on an ultrasonic cell crusher with a power of 300W, working for 3s, and resting for 3s. When the bacterial suspension is clear, the crushing can be stopped. Finally, the crushed liquid is centrifuged at 4℃ and 14000rpm for 4min. The supernatant is the crude enzyme solution, which is stored in a -20℃ refrigerator.

[0065] According to the His-Tag tag on the fusion protein, the target protein was purified by nickel affinity chromatography, and the target protein was eluted with imidazole solutions of different concentrations. Finally, the molecular weight and purity of the target protein were detected by 10% SDS-PAGE electrophoresis. Figure 2 As shown in A (M: 25-180kDa protein marker; Lane 4: DhUGT31 crude enzyme solution; Lane 5: pET-28a(+) empty vector), the crude enzyme solution has many miscellaneous bands, and the expression of the target gene cannot be determined; while the purified protease solution has a single band in the electrophoresis diagram, and the size is consistent with the molecular weight of the theoretical protein plus the recombinant tag ( Figure 2 Lane 4 (B): 25-130 kDa protein marker; Lane 4: purified DhUGT31 protease solution), indicating that the protein was successfully expressed in the supernatant and the purified protein can be used for subsequent experiments.

[0066] Example 3 In vitro enzyme activity detection

[0067] With reference to the known substrates of flavonoid C-glycosyltransferase, it is speculated that the substrates for DhCGTs activity detection are mainly flavonoids.

[0068] 1. Enzyme activity reaction system: 10 μg pure enzyme, 0.5 mM substrate, 5 mM sugar donor, 14 mM β-mercaptoethanol, dilute to 200 μL with 50 mM, pH = 8.0 Tris-HCl buffer. After the reaction solution is in a water bath at 30°C for 12 hours, an equal volume of pre-cooled methanol is added, vortexed and mixed, and centrifuged at 4°C, 14000 rpm for 4 minutes, and the supernatant is taken for high performance liquid chromatography detection.

[0069] 2. HPLC conditions

[0070] Phase A was 0.1% formic acid water, phase B was acetonitrile, the mobile phase flow rate was 0.8 mL / min, the injection volume was 20 μL, the column temperature was 30°C, and the gradient elution system was 5% to 20% B (0 to 5 min), 20% to 22% B (5 to 8 min), 22% to 25% B (8 to 17 min), 25% to 35% B (17 to 23 min), 35% to 50% B (23 to 25 min), 50% to 95% B (25 to 32 min), 95% B (32 to 37 min), 95% to 5% B (37 to 38 min), and 5% B (38 to 42 min).

[0071] 3. LC-MS conditions:

[0072] The detection mode was negative ion mode; the mobile phase composition was consistent with HPLC, the detection source was an electrospray ion source, and the acquisition mode was AutoMS 2 ; Capillary voltage 3500V; sheath gas temperature 350℃, flow rate 11L / min; drying gas temperature 325℃, flow rate 8L / min; mass-to-charge ratio scanning range 100-1700m / z; collision voltage 175V; collision energy 15-50eV.

[0073] 4. Test results:

[0074] Results Figure 3 When DhUGT31 used 2-hydroxynaringenin as a substrate, three product peaks were observed in the reaction. By comparing the retention time and mass-to-charge ratio m / z of the standard, it was found that the products were vitexin, isovitexin and vitexin (23-a, 23-b, and 23-c were vitexin, isovitexin and vitexin, respectively).

[0075] Example 4

[0076] Enzyme kinetic parameters detection

[0077] Using 2-hydroxynaringenin as the glycosyl acceptor and UDP-Glc as the sugar donor, the effects of pH, temperature, metal ions and reaction time on the catalytic activity were investigated.

[0078] 1. Temperature: 2-hydroxynaringenin was used as the glycosyl acceptor and UDP-Glc was used as the sugar donor to investigate the changes in enzyme activity at different reaction temperatures (4°C, 20°C, 30°C, 37°C, 40°C, 42°C, 50°C, 60°C and 70°C). The reaction system contained 10 μg of pure protein, 0.5 mM substrate, 5 mM sugar donor, 14 mM β-mercaptoethanol, and was fixed to 200 μL with 50 mM, pH=8.0 Tris-HCl buffer. The reaction solution was reacted at each temperature for 1 h. After the reaction, an equal volume of pre-cooled methanol was immediately added to the reaction system to terminate the reaction. After centrifugation, the supernatant was taken for HPLC detection. Three parallel tests were set for each group of reactions. The conversion rate of the substrate was estimated based on the peak area ratio in the chromatogram.

[0079] 2. pH: Investigate the effects of different pH buffers of 50mM: 5.0-6.0, Citric acid-sodium citrate Buffer; 6.0-8.0, Na2HPO4-NaH2PO4 Buffer; 7.0-9.0, Tris-HCl Buffer; 9.0-10.0, Na2CO3-NaHCO3 Buffer on enzyme activity. The reaction system is: 14mMβ-mercaptoethanol, 5mMUDP-Glc, 10μg protein, 0.5mM compound 2-hydroxynaringenin in a 200μL reaction system, supplemented to the specified volume with buffers of different pH. The reaction solution was placed at 30℃ for 1h, and an equal volume of pre-cooled methanol was immediately added after the reaction. After centrifugation, the supernatant was taken for HPLC detection. To ensure the reliability of the data, three replicate samples were set up for each group of reactions, and the final conversion rate was calculated by the peak area of ​​the chromatogram.

[0080] 3. Metal ions: The acceptor molecule of the reaction solution is selected as the compound 2-hydroxynaringenin, and the donor is selected as UDP-Glc. Different divalent metal ions are investigated: Mg 2+ , Ca 2+ , Fe 2+ 、Zn 2+ 、Co 2+ , Ba 2+ , Mn 2+ The effect of EDTA on enzyme activity. A 200 μL reaction system contains 14 mM β-mercaptoethanol, 5 mM UDP-Glc, 10 μg protein, 0.5 mM substrate, 5 mM divalent metal ions, and 50 mM Tris-HCl buffer at pH = 8.0 is added to the specified volume. The reaction solution is placed at 30°C for 1 hour, and an equal volume of pre-cooled methanol is immediately added after the reaction is completed, and centrifuged at 14000 rpm and 4°C for 4 minutes. Three replicate samples are set up for each group of reactions, and the supernatant is taken for HPLC detection, and the catalytic efficiency of the enzyme is calculated at the maximum absorption wavelength of the substrate.

[0081] 4. Reaction time: 200 μL Tris-HCl (50 mM, pH = 8.0) reaction system contains 14 mM β-mercaptoethanol, 5 mM UDP-Glc, 10 μg purified protein, 0.5 mM substrate 2-hydroxynaringenin, and reacts for 5 min, 10 min, 20 min, 30 min, 60 min, 120 min, 240 min, 480 min, 720 min in a 30 ° C water bath. After the reaction, an equal volume of pre-cooled methanol was quickly added to each reaction solution to terminate the reaction, and centrifuged at 14000 rpm and 4 ° C for 4 min. The supernatant was tested on HPLC, and the conversion rate of the substrate was calculated. To ensure the accuracy of the data, three parallel experiments were set up for each group, and the substrate conversion rate was calculated according to the ratio of the peak area in the HPLC spectrum.

[0082] 5. Michaelis constant Km: The reaction system of DhCGT31 is: 200 μL Na2HPO4-NaH2PO4 (50 mM, pH = 8.0) containing 14 mM β-mercaptoethanol, 5 mM UDP-Glc, 5 μg purified protein, 5 mM Mn 2+ , 2-hydroxynaringenin was selected as the substrate, and the concentrations were: 50, 100, 150, 200, 250, 300, 350, 400 μM, respectively, and the reaction was carried out at 30°C for 10 min. Immediately after the reaction, an equal volume of pre-cooled methanol was added to each reaction, and the supernatant was taken after centrifugation and detected on HPLC. The detection wavelength was the maximum absorption wavelength of the substrate, and the conversion rate of the substrate was calculated based on the peak area. To ensure the accuracy of the data, three parallel experiments were set up in each group. The Michaelis constant was calculated by the Michaelis equation and the Lineweaver-Burk plot method.

[0083] 6. Test results:

[0084] Enzyme kinetic studies have shown that ( Figure 4 ), DhUGT31 has the highest enzyme activity at 30℃, and its catalytic activity gradually decreases with the increase of temperature. When the temperature rises to 60℃, the enzyme activity is almost completely lost. The optimal pH of the reaction solution is 8.0, and the catalytic activity in Na2HPO4-NaH2PO4 buffer is higher than that in Tris-HCl. The enzyme is not dependent on metal ions. Among divalent metal ions, Mn 2+ , Ca 2+ Mg 2+ Both can improve enzyme activity, among which Mn 2+The promotion effect is the best. In addition, the reaction can completely consume 0.5mM substrate after 100min. UDP-Glc was selected as the sugar donor with a constant concentration of 5mM, 2-hydroxynaringenin was selected as the acceptor with a concentration gradient of 0.05-0.4mM, and the Lineweaver-Burk method was used to plot ( Figure 4 E), the apparent Michaelis constant Km was calculated by the double reciprocal equation to be 17.41 μM.

[0085] The above description of the disclosed embodiments enables one skilled in the art to implement or use the present invention. Various modifications to the above embodiments will be apparent to one skilled in the art, and the general principles defined herein may be implemented in other embodiments without departing from the spirit or scope of the present invention. Therefore, the present invention will not be limited to the embodiments shown herein, but rather to the widest scope consistent with the principles and novel features disclosed herein.

Claims

1. A C-glycosyltransferase, the amino acid sequence of which is shown in SEQ ID NO.

2.

2. A C-glycosyltransferase gene, the sequence of which is a nucleotide sequence encoding an amino acid sequence as shown in SEQ ID NO.2, or a sequence that is fully complementary to a nucleotide sequence encoding an amino acid sequence as shown in SEQ ID NO.

2.

3. Use of the C-glycosyltransferase according to claim 1 in the synthesis of flavonoid carbonyl glycoside compounds.

4. Use of the C-glycosyltransferase gene according to claim 2 in the synthesis of flavonoid carbonyl glycoside compounds.

5. A method for synthesizing flavonoid glycoside compounds, the method comprising the following steps: 1) obtaining the C-glycosyltransferase according to claim 1; 2) Using the C-glycosyltransferase in step 1) to catalyze the synthesis of flavonoid carbonyl glycoside compounds in an enzyme activity reaction system.

6. A method for synthesizing flavonoid glycosides according to claim 5, characterized in that: In step 1), the C-glycosyltransferase is obtained by prokaryotic expression or by chemical synthesis.

7. A method for synthesizing flavonoid glycosides according to claim 5, characterized in that: The enzyme activity reaction system in step 2) contains the C-glycosyltransferase, UDP-Glc and flavonoid compounds described in step 1).

8. A method for synthesizing flavonoid glycosides according to claim 5, characterized in that: The enzyme activity reaction system in step 2) also contains divalent cations.

9. A method for synthesizing flavonoid glycosides as claimed in claim 5, characterized in that: The reaction temperature of the enzyme activity reaction system in step 2) is 4-42°C.

10. A method for synthesizing flavonoid glycosides according to claim 5, characterized in that: The pH of the enzyme activity reaction system in step 2) is 6.0-10.0.

Citation Information

Cited By

  • Dendrobium huoshanense glycosyl transferase and application thereof in synthesis of antioxidant flavonoid bioside compound

    CN121271820A